Ubrogepant is prescribed for:
- Acute migraine treatment
- Migraine with or without aura
- Neurologic headache management
Unlike injectables, this is an oral CGRP antagonist for treating acute attacks.
Generic Name: Ubrogepant
Brand Names: Ubrelvy
Ubrogepant is an oral CGRP receptor antagonist for acute treatment of migraine attacks.
Ubrogepant is prescribed for:
Unlike injectables, this is an oral CGRP antagonist for treating acute attacks.
Common side effects:
Generally well tolerated with no cardiovascular contraindications like triptans.
Ubrogepant is the first oral CGRP receptor antagonist ("gepant") approved for acute migraine treatment.
50 mg or 100 mg at migraine onset. May repeat once after 2 hours if needed.
Learn more at MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Ubrogepant? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.